[go: up one dir, main page]

WO2015022575A3 - Procédé de préparation d'un agoniste de gc-c - Google Patents

Procédé de préparation d'un agoniste de gc-c Download PDF

Info

Publication number
WO2015022575A3
WO2015022575A3 PCT/IB2014/001570 IB2014001570W WO2015022575A3 WO 2015022575 A3 WO2015022575 A3 WO 2015022575A3 IB 2014001570 W IB2014001570 W IB 2014001570W WO 2015022575 A3 WO2015022575 A3 WO 2015022575A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
agonist
linaclotide
coupling
solid phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2014/001570
Other languages
English (en)
Other versions
WO2015022575A2 (fr
Inventor
Agasaladinni NAGANA GOUD
Vadlamani SURESH KUMAR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auro Peptides Ltd
Original Assignee
Auro Peptides Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auro Peptides Ltd filed Critical Auro Peptides Ltd
Publication of WO2015022575A2 publication Critical patent/WO2015022575A2/fr
Publication of WO2015022575A3 publication Critical patent/WO2015022575A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne un procédé de préparation de Linaclotide par le couplage de deux ou trois fragments appropriés par une synthèse en phase solide.
PCT/IB2014/001570 2013-08-13 2014-08-11 Procédé de préparation d'un agoniste de gc-c Ceased WO2015022575A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2574CHE2013 2013-08-13
IN2574CH2013 2013-08-13

Publications (2)

Publication Number Publication Date
WO2015022575A2 WO2015022575A2 (fr) 2015-02-19
WO2015022575A3 true WO2015022575A3 (fr) 2015-07-02

Family

ID=51743467

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2014/001570 Ceased WO2015022575A2 (fr) 2013-08-13 2014-08-11 Procédé de préparation d'un agoniste de gc-c

Country Status (1)

Country Link
WO (1) WO2015022575A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016038497A1 (fr) * 2014-09-08 2016-03-17 Auro Peptides Ltd Procédé de préparation de linaclotide
CN107001416B (zh) * 2014-12-26 2021-01-15 深圳华大生命科学研究院 芋螺毒素肽κ-CPTx-btl04、其制备方法及应用
WO2016101276A1 (fr) * 2014-12-26 2016-06-30 深圳华大基因研究院 Peptide de conotoxine k-cptx-btl03, procédé de préparation correspondant, et utilisations dudit composé
EP3239167B1 (fr) * 2014-12-26 2021-06-23 BGI Shenzhen Derivé du peptide conotoxine kappa-cptx-btl01, méthode de préparation et utilisations
CN106892968B (zh) * 2015-12-18 2021-11-05 深圳翰宇药业股份有限公司 一种利那洛肽的合成方法
WO2017134687A1 (fr) * 2016-02-03 2017-08-10 Cipla Limited Procédé de préparation d'agoniste de guanylate cyclase 2c
CN111732632B (zh) * 2020-07-16 2021-12-21 台州吉诺生物科技有限公司 一种利那洛肽的合成方法
CN112321681B (zh) * 2020-10-29 2021-12-14 杭州信海医药科技有限公司 一种利那洛肽的制备方法
EP4194464A1 (fr) 2021-12-13 2023-06-14 Chemi SPA Procédé de fabrication pour la production de linaclotide

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050020811A1 (en) * 2003-01-28 2005-01-27 Currie Mark G. Methods and compositions for the treatment of gastrointestinal disorders
WO2012118972A2 (fr) * 2011-03-01 2012-09-07 Synegy Pharmaceuticals Inc. Procédé de préparation d'agonistes du guanylate cyclase c

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050020811A1 (en) * 2003-01-28 2005-01-27 Currie Mark G. Methods and compositions for the treatment of gastrointestinal disorders
WO2012118972A2 (fr) * 2011-03-01 2012-09-07 Synegy Pharmaceuticals Inc. Procédé de préparation d'agonistes du guanylate cyclase c

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MIRIAM GÓNGORA-BENÍTEZ ET AL: "Optimized Fmoc solid-phase synthesis of the cysteine-rich peptide linaclotide", BIOPOLYMERS, vol. 96, no. 1, 1 January 2011 (2011-01-01), pages 69 - 80, XP055047758, ISSN: 0006-3525, DOI: 10.1002/bip.21480 *

Also Published As

Publication number Publication date
WO2015022575A2 (fr) 2015-02-19

Similar Documents

Publication Publication Date Title
WO2015022575A3 (fr) Procédé de préparation d'un agoniste de gc-c
WO2014206561A8 (fr) Structures d'anticorps
WO2011138281A3 (fr) Procédé de production de dithiine-tétracarboxy-diimides
HK1217023A1 (zh) 新型抗体
EP3077399A4 (fr) Procédés utiles pour la synthèse d'analogues d'halichondrine b
WO2015051030A8 (fr) Polypeptides stabilisés et utilisations de ces derniers
EP2981543A4 (fr) Nouveaux antagonistes peptidiques d' 4 7
EP3432906A4 (fr) Procédés de synthèse d'antagonistes de peptide alpha4beta7
EP2992021A4 (fr) Nouveau procédé de clonage, d'expression et de purification pour la préparation de ranibizumab
WO2014125506A3 (fr) Procédé de préparation d'ivacaftor et de ses intermédiaires
WO2015029074A3 (fr) Compositions d'eltrombopag
WO2014188011A3 (fr) Procédé de préparation de linaclotide
EP3694499A4 (fr) Nouveau procédé de préparation de lifitegrast
WO2016009401A3 (fr) Préparation du phosphate de tédizolid
EP3016935A4 (fr) Procédé pour la préparation d'intermédiaire de dolutégravir
WO2015181802A3 (fr) Composition pharmaceutique orale d'isotrétinoïne
WO2015097717A3 (fr) Procédé amélioré de préparation de β-carotène
WO2015063795A3 (fr) Nouveau procédé de préparation de noréphédrine optiquement pure et de ses dérivés
WO2014118606A3 (fr) Nouveau procédé de préparation de silodosine
EP3024326A4 (fr) Nouveau procédé pour la préparation de lévothyroxine sodique
EP3027622B8 (fr) Procede pour la preparation de oxymorphone
HUE040536T2 (hu) Eljárás halogén-N,N-dimetilbenzilaminok elõállítására
PL3250556T3 (pl) Sposoby otrzymywania związków, takich jak 3-arylobutanale, stosowanych w syntezie medetomidyny
WO2016012938A3 (fr) Procédé amélioré de préparation du linaclotide amorphe
PT2981518T (pt) Um processo melhorado para a preparação de maleato de fluvoxamina

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14786243

Country of ref document: EP

Kind code of ref document: A2